These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6544849)

  • 1. Do patients and physicians agree on the assessment of voice quality in laryngeal cancer?
    Sutherland HJ; Llewellyn-Thomas H; Hogg SA; Keane TJ; Harwood AR; Till JE; Boyd NF
    J Otolaryngol; 1984 Oct; 13(5):325-30. PubMed ID: 6544849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice outcomes after radiotherapy treatment for early glottic cancer: assessment using multidimensional tools.
    Bibby JR; Cotton SM; Perry A; Corry JF
    Head Neck; 2008 May; 30(5):600-10. PubMed ID: 18098302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antituberculosis treatment on self assessment, perceptual analysis and acoustic analysis of voice quality in laryngeal tuberculosis patients.
    Yelken K; Guven M; Topak M; Gultekin E; Turan F
    J Laryngol Otol; 2008 Apr; 122(4):378-82. PubMed ID: 17592656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of irregular voices after total and laser surgical partial laryngectomy.
    Olthoff A; Mrugalla S; Laskawi R; Fröhlich M; Stuermer I; Kruse E; Ambrosch P; Steiner W
    Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):994-9. PubMed ID: 12975275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between ratings of voice quality and quality of life measures.
    Murry T; Medrado R; Hogikyan ND; Aviv JE
    J Voice; 2004 Jun; 18(2):183-92. PubMed ID: 15193651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability and validity of patient self-rating of their own voice quality.
    Lee M; Drinnan M; Carding P
    Clin Otolaryngol; 2005 Aug; 30(4):357-61. PubMed ID: 16209679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising outcome assessment of voice interventions, II: Sensitivity to change of self-reported and observer-rated measures.
    Steen IN; MacKenzie K; Carding PN; Webb A; Deary IJ; Wilson JA
    J Laryngol Otol; 2008 Jan; 122(1):46-51. PubMed ID: 17498325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of clinician-based (GRBAS and CAPE-V) and patient-based (V-RQOL and IPVI) documentation of voice disorders.
    Karnell MP; Melton SD; Childes JM; Coleman TC; Dailey SA; Hoffman HT
    J Voice; 2007 Sep; 21(5):576-90. PubMed ID: 16822648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature and severity of voice disorders in lung cancer patients.
    Lee CF; Carding PN; Fletcher M
    Logoped Phoniatr Vocol; 2008; 33(2):93-103. PubMed ID: 18569648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived vocal morbidity in a problem asthma clinic.
    Stanton AE; Sellars C; Mackenzie K; McConnachie A; Bucknall CE
    J Laryngol Otol; 2009 Jan; 123(1):96-102. PubMed ID: 18644167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice handicap evaluation after supracricoid partial laryngectomy.
    Makeieff M; de la Breteque A; Guerrier B; Giovanni A
    Laryngoscope; 2009 Apr; 119(4):746-50. PubMed ID: 19205015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer.
    Kazi R; Venkitaraman R; Johnson C; Prasad V; Clarke P; Newbold K; Rhys-Evans P; Nutting C; Harrington K
    Radiother Oncol; 2008 May; 87(2):230-6. PubMed ID: 18237804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voice quality of prepubescent children with quiescent recurrent respiratory papillomatosis.
    Lindman JP; Gibbons MD; Morlier R; Wiatrak BJ
    Int J Pediatr Otorhinolaryngol; 2004 May; 68(5):529-36. PubMed ID: 15081224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Registration of the vocal field for the clinical assessment of voice].
    Shyupshinskene N; Uloza V
    Vestn Otorinolaringol; 1997; (4):31-3. PubMed ID: 9334013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures.
    Wedman J; Heimdal JH; Elstad I; Olofsson J
    Eur Arch Otorhinolaryngol; 2002 Nov; 259(10):547-50. PubMed ID: 12434191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngeal fractures: clinical findings and considerations on suboptimal outcome.
    Juutilainen M; Vintturi J; Robinson S; Bäck L; Lehtonen H; Mäkitie AA
    Acta Otolaryngol; 2008 Feb; 128(2):213-8. PubMed ID: 17851956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.